Adalimumab Biosimilar – Anti-TNF alpha mAb – Research Grade

(1 customer review)
Reference:
Size

,

Brand

Product type

Clonality

Expression system

Description of Adalimumab Biosimilar - Anti-TNF alpha mAb - Research Grade

Description of Adalimumab Biosimilar - Anti-TNF alpha mAb - Research Grade

General information about Adalimumab

Adalimumab is a recombinant, human IgG1 monoclonal antibody directed against tumor necrosis factor-alpha (TNF-alpha), with immunomodulating activity. Upon administration, adalimumab binds to TNF-alpha, thereby preventing its binding to the p55 and p75 TNF cell surface receptors and inhibiting TNF-mediated immune responses. TNF-alpha, a pro-inflammatory cytokine, is upregulated in various autoimmune diseases. Check for active clinical trials using this agent.

Product nameAdalimumab Biosimilar - Anti-TNF alpha mAb - Research Grade
SourceDrugBank DB00051
SpeciesHuman
Molecular weight144kDa
Purity>90%
BufferPBS pH7.5
Delivery conditionBlue ice (+4°C)
Delivery Time3-5 days if in stock; 3-5 weeks if production needed
Storage condition4°C for short term; -20°C for long term
BrandProteoGenix
Aliases /SynonymsAdalimumab
ReferencePX-TA1001
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG1
ClonalityMonoclonal Antibody
SourceDrugBank DB00051
Product nameAdalimumab Biosimilar - Anti-TNF alpha mAb - Research Grade
SourceDrugBank DB00051
SpeciesHuman
Expression systemMammalian cells
Molecular weight144kDa
Purity>90%
BufferPBS pH7.5
Delivery conditionBlue ice (+4°C)
Delivery Time3-5 days if in stock; 3-5 weeks if production needed
Storage condition4°C for short term; -20°C for long term
BrandProteoGenix
Aliases /SynonymsAdalimumab
ReferencePX-TA1001
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG1
ClonalityMonoclonal Antibody
SourceDrugBank DB00051

1 review for Adalimumab Biosimilar – Anti-TNF alpha mAb – Research Grade

  1. Ofer Gover

    We used this ab to reduce as a negative control for reducing caco-2 (IEC) cells exitation by exugenues TNFa. We measured IL8 secreation as a result of TNFa stimulation. 1ug/mL ofAdalimumab Biosimilar – Anti-TNF alpha mAb was enough to completly abolish IL8 secreation by TNFa stimulation in caco-2 cells.

Add a review

Your email address will not be published.


Clear
OK

Please select the country of delivery so that we can send you the quotation including shipping costs.

Thank you for your request! You will receive your quotation per e-mail in a few seconds.

If you did not receive your quotation, please check your spam folder.

Contact us to order

+33 (0)3 90 20 54 70

Write us

Categories: